Forbes

Elevance Health’s decision to shakeup its management team is the latest sign it may take more time for the health insurance industry to rebound.

It’s widely known that weight regain is likely after discontinuing medication. But it’s the reversal of cardiovascular risk reduction that researchers found conspicuous.

The Trump administration is investigating admission policies at three medical schools to pressure them to stop building a more diverse healthcare workforce for the U.S.

Repealing the HMO Act is not on any politician’s agenda. But perhaps a better regulated, less heavily profit-oriented system of multiple payers could work in the U.S.

In this week’s edition of InnovationRx, we look the billionaire dentist, Wegovy by subscription, Kailera’s planned IPO, and more.

Targeting organ‑specific gene “switches” can reverse key markers of liver aging in mice, suggesting aging might be slowed one organ at a time rather than bodywide.

A doctor breaks down how the new AHA dietary guidelines differ from the federal dietary guidelines and what that means for public health.